Innovative Immunology Biotech Windward Bio Lists on Nasdaq

laotiantimes.com · politics
Full story

Windward Bio began trading on the Nasdaq on November 13, 2026. The clinical-stage biotechnology company is a portfolio company of Qiming Venture Partners. The initial public offering price was set at $17.00 per share. By the end of the first trading day, shares closed at $28.50. This represents a 68% increase from the original IPO price.

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the […]

Read full article → Compare